SWM
SRNE

Salvus Wealth Management’s Sorrento Therapeutics, Inc. SRNE Stock Holding History

Salvus Wealth Management’s Portfolio SRNE Stock Details SRNE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-40,911
Closed -$36.2K – 108
2022
Q4 		$36.2K Hold
40,911
– – 0.03% 95
2022
Q3 		$64K Hold
40,911
– – 0.06% 96
2022
Q2 		$82K Buy
+40,911
New +$82K 0.07% 97